Stephen J. Carriere - Jan 19, 2023 Form 4 Insider Report for Evelo Biosciences, Inc. (EVLO)

Role
Principal Accounting Officer
Signature
/s/ Stephen J. Carriere
Stock symbol
EVLO
Transactions as of
Jan 19, 2023
Transactions value $
-$160
Form type
4
Date filed
1/23/2023, 04:35 PM
Previous filing
Jan 21, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EVLO Common Stock Options Exercise +354 354 Jan 19, 2023 Direct F1, F2
transaction EVLO Common Stock Sale -$160 -151 -42.66% $1.06 203 Jan 23, 2023 Direct F3, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EVLO Restricted Stock Units Options Exercise $0 -354 -24.98% $0.00 1.06K Jan 19, 2023 Common Stock 354 $0.00 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Settlement of shares of Common Stock acquired upon the vesting of Restricted Stock Units previously granted to the reporting person.
F2 The price is N/A.
F3 The sale reported on this Form 4 represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units previously granted to the reporting person. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the reporting person.
F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $1.06 to $1.0712, inclusive. The reporting person undertakes to provide to the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote of this Form 4.
F5 The Restricted Stock Units vest in four substantially equal annual installments at the end of each annual anniversary of the date of grant, subject to continued employment on such dates.